Indian benchmarks notched their fourth straight week of gains on Friday, their longest winning streak in 2025 so far, fuelled ...

Investing in Indian Small Caps offers high-growth potential and undervalued opportunities for investors. India's fast-growing economy, consumer demand, and government's fiscal approach support the ...

The Trump administration’s decision to ease the $100,000 H-1B visa fee brings relief to thousands of Indian professionals and ...

India-focused ETFs are attracting investor attention amid potential U.S. tariff cuts and trade concessions. Here's which ETFs ...

In this article, we will take a look at 15 of the biggest Indian companies by market cap. If you want to see more of the biggest Indian companies by market cap, go directly to 5 Biggest Indian ...

SMIN invests in small-cap Indian stocks. The fund has technically out-performed U.S. equities recently; however, perhaps a lot of this has been due to favorable cyclical positioning and international ...

India is pivoting to domestic growth levers as the Centre and states ramp up capex and GST rate cuts fuel record festive ...

Among the top-performing midcap funds, Motilal Oswal Midcap Fund leads with 23.45% SIP CAGR, turning a Rs 10,000 monthly SIP ...

Five small-cap mutual funds Quant, Nippon, Tata, Bandhan, and Invesco have delivered 30%+ annualised returns over five years, outperforming benchmarks. With consistent pre-sales growth and low expense ...

NEW DELHI/MUMBAI (Reuters) - India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior ...